Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1861 2
1862 2
1866 1
1872 1
1938 2
1949 1
1951 2
1953 1
1954 1
1956 3
1958 1
1959 2
1960 4
1961 3
1962 4
1963 2
1964 3
1965 3
1966 2
1967 4
1968 3
1969 2
1970 3
1971 2
1972 4
1973 7
1974 3
1976 4
1977 3
1978 5
1979 7
1980 3
1981 5
1982 8
1983 7
1984 3
1985 4
1986 4
1987 2
1988 5
1989 4
1990 4
1991 1
1992 6
1993 3
1994 5
1995 4
1996 5
1997 1
1998 3
1999 6
2000 4
2001 7
2003 11
2004 3
2005 4
2006 5
2007 6
2008 4
2009 3
2010 6
2011 3
2012 7
2013 6
2014 4
2015 6
2016 6
2017 9
2018 10
2019 14
2020 14
2021 13
2022 13
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced detection of circulating tumor DNA by fragment size analysis.
Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Østrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sørensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N. Mouliere F, et al. Among authors: smith cg. Sci Transl Med. 2018 Nov 7;10(466):eaat4921. doi: 10.1126/scitranslmed.aat4921. Sci Transl Med. 2018. PMID: 30404863 Free PMC article.
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.
Gale D, Heider K, Ruiz-Valdepenas A, Hackinger S, Perry M, Marsico G, Rundell V, Wulff J, Sharma G, Knock H, Castedo J, Cooper W, Zhao H, Smith CG, Garg S, Anand S, Howarth K, Gilligan D, Harden SV, Rassl DM, Rintoul RC, Rosenfeld N. Gale D, et al. Among authors: smith cg. Ann Oncol. 2022 May;33(5):500-510. doi: 10.1016/j.annonc.2022.02.007. Epub 2022 Mar 17. Ann Oncol. 2022. PMID: 35306155 Free PMC article.
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
Hudecova I, Smith CG, Hänsel-Hertsch R, Chilamakuri CS, Morris JA, Vijayaraghavan A, Heider K, Chandrananda D, Cooper WN, Gale D, Garcia-Corbacho J, Pacey S, Baird RD, Rosenfeld N, Mouliere F. Hudecova I, et al. Among authors: smith cg. Genome Res. 2022 Feb;32(2):215-227. doi: 10.1101/gr.275691.121. Epub 2021 Dec 20. Genome Res. 2022. PMID: 34930798 Free PMC article.
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Santonja A, Cooper WN, Eldridge MD, Edwards PAW, Morris JA, Edwards AR, Zhao H, Heider K, Couturier DL, Vijayaraghavan A, Mennea P, Ditter EJ, Smith CG, Boursnell C, Manzano García R, Rueda OM, Beddowes E, Biggs H, Sammut SJ, Rosenfeld N, Caldas C, Abraham JE, Gale D. Santonja A, et al. Among authors: smith cg. EMBO Mol Med. 2023 Jun 7;15(6):e16505. doi: 10.15252/emmm.202216505. Epub 2023 May 10. EMBO Mol Med. 2023. PMID: 37161793 Free PMC article.
Response.
Smith CG, West H, Harris R, Idziaszczyk S, Maughan TS, Kaplan R, Richman S, Quirke P, Seymour M, Moskvina V, Steinke V, Propping P, Hes FJ, Wijnen J, Cheadle JP. Smith CG, et al. J Natl Cancer Inst. 2014 Apr 26;106(5):dju087. doi: 10.1093/jnci/dju087. J Natl Cancer Inst. 2014. PMID: 24771876 No abstract available.
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Mourcin F, Roulois D, Turner J, Sylvestre M, Asam S, Glaysher B, Bowman SJ, Fearon DT, Filer A, Tarte K, Luther SA, Fisher BA, Buckley CD, Coles MC, Barone F. Nayar S, et al. Among authors: smith cg. Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13490-13497. doi: 10.1073/pnas.1905301116. Epub 2019 Jun 18. Proc Natl Acad Sci U S A. 2019. PMID: 31213547 Free PMC article.
Extracting quantitative dielectric properties from pump-probe spectroscopy.
Ashoka A, Tamming RR, Girija AV, Bretscher H, Verma SD, Yang SD, Lu CH, Hodgkiss JM, Ritchie D, Chen C, Smith CG, Schnedermann C, Price MB, Chen K, Rao A. Ashoka A, et al. Among authors: smith cg. Nat Commun. 2022 Mar 17;13(1):1437. doi: 10.1038/s41467-022-29112-y. Nat Commun. 2022. PMID: 35301311 Free PMC article.
CHLORAMPHENICOL.
SMITH CG, HINMAN JW. SMITH CG, et al. Prog Ind Microbiol. 1963;4:137-63. Prog Ind Microbiol. 1963. PMID: 14150252 Review. No abstract available.
Zosteriform multiple leiomyomas.
Smith CG, Glaser DA, Leonardi C. Smith CG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):272-3. doi: 10.1016/s0190-9622(98)70602-4. J Am Acad Dermatol. 1998. PMID: 9486688 No abstract available.
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Stewart GD, Welsh SJ, Ursprung S, Gallagher FA, Jones JO, Shields J, Smith CG, Mitchell TJ, Warren AY, Bex A, Boleti E, Carruthers J, Eisen T, Fife K, Hamid A, Laird A, Leung S, Malik J, Mendichovszky IA, Mumtaz F, Oades G, Priest AN, Riddick ACP, Venugopal B, Welsh M, Riddle K, Hopcroft LEM; NAXIVA Trial Group; Jones RJ. Stewart GD, et al. Among authors: smith cg. Br J Cancer. 2022 Oct;127(6):1051-1060. doi: 10.1038/s41416-022-01883-7. Epub 2022 Jun 23. Br J Cancer. 2022. PMID: 35739300 Free PMC article. Clinical Trial.
318 results